FDA Import Refusal 9TV-1001381-1/21/1 — Attix Pharmaceuticals Inc
The FDA refused shipment 9TV-1001381-1/21/1 from Attix Pharmaceuticals Inc (Canada) on Feb 21, 2018. The refused product falls under Drugs and Biologics — CHLORAMBUCIL (ANTI-NEOPLASTIC). Cited charge: 16 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 21, 2018
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62ICT13 CHLORAMBUCIL (ANTI-NEOPLASTIC)
- Charges
- 16